Which pharmaceutical giant rebranded its blockbuster pain medication from 'Darvon' to 'Propoxyphene' in the early 2000s, shortly before the FDA ultimately required its withdrawal from the US market?

In the high-stakes world of pharmaceutical marketing, brand names can make or break a medication's success. Companies invest millions in developing memorable, trustworthy names that physicians can easily pronounce and patients can recognize. This poll tests your knowledge about one of the most significant pharmaceutical rebranding efforts in recent history - when a major corporation renamed a blockbuster medication to improve market perception and overcome negative associations.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Eli Lilly
Pfizer
Johnson & Johnson
Merck